| Range: | 5.87-11.83 | Vol Avg: | 5044 | Last Div: | 0 | Changes: | -0.12 |
| Beta: | 0 | Cap: | 0.00B | Currency: | USD | Exchange: | NASDAQ |
| Sector: | IPO: | Thu Jan 13 2022 | Empoloyees: | ||||
| CUSIP: | CIK: | 0001873280 | ISIN: | CA46437W1059 | Country: | ||
XDNA 0.00 Stock Price Kelly CRISPR & Gene Editing Technology ETF
The adviser employs a “passive management” investment approach designed to track the total return performance of the index. The index is a rules-based index that consists of the stocks or corresponding depositary receipts of companies engaged in the creation, development, production, operation, provision, distribution, ownership, servicing, licensing, leasing or franchising of at least one of the DNA Modification Technology Business. The fund invests at least 80% of its net assets in DNA Modification Technology Companies. It is non-diversified.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow